J. Safra Sarasin Holding’s ResMed RMD Stock Holding History

J. Safra Sarasin Holding’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$440K	Buy	2,257 +676	+43%	+$140K	0.01%	568
2026 Q1	$354K	Buy	1,581 +16	+1%	+$3.99K	0.01%	459
2025 Q4	$377K	Sell	1,565 -10,794	-87%	-$2.76M	0.01%	435
2025 Q3	$3.38M	Buy	12,359 +5,001	+68%	+$1.37M	0.05%	169
2025 Q2	$1.9M	Sell	7,358 -2,608	-26%	-$622K	0.03%	228
2025 Q1	$2.23M	Sell	9,966 -582	-6%	-$136K	0.04%	209
2024 Q4	$2.41M	Sell	10,548 -1,470	-12%	-$354K	0.04%	208
2024 Q3	$2.93M	Sell	12,018 -376	-3%	-$84K	0.05%	177
2024 Q2	$2.37M	Buy	+12,394	New	+$2.51M	0.04%	213

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

J. Safra Sarasin Holding's RMD Position: Q2 2026 in Review

J. Safra Sarasin Holding increased its ResMed (RMD) stake by 43% in Q2 2026, buying an estimated $140K and bringing the position to 2,257 shares worth $440K. The position accounts for 0.01% of the portfolio, ranked #568.

J. Safra Sarasin Holding first reported a position in RMD in Q2 2024 and has held it in 9 quarters since. The position peaked at $3.38M in Q3 2025. 891 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

J. Safra Sarasin Holding held 2,257 shares of ResMed worth $440K as of Q2 2026.
J. Safra Sarasin Holding bought 676 ResMed shares in Q2 2026, an estimated $140K.
ResMed made up 0.01% of J. Safra Sarasin Holding's portfolio in Q2 2026, its #568 holding.
J. Safra Sarasin Holding first reported a position in ResMed in Q2 2024 and has held it in 9 quarters since.
J. Safra Sarasin Holding's ResMed position peaked at $3.38M in Q3 2025.
891 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on J. Safra Sarasin Holding's 13F filing for Q2 2026, filed 31 Jul 2026.